Cite
HARVARD Citation
Shankar, A. et al. (2021). Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma. European journal of cancer. pp. 38-46. [Online].